ストックスクリーナーアプリを入手
15.10
1.55%
0.23
アフターアワーズ：
15.10
Y Mabs Therapeutics Inc (YMAB) 最新ニュース
(YMAB) Trading Advice - Stock Traders Daily
Vanguard Group Inc's Strategic Acquisition in Y-mAbs Therapeutics Inc - GuruFocus.com
Y-mAbs enters Japan market with Nobelpharma for cancer therapy By Investing.com - Investing.com Canada
Y-mAbs and Nobelpharma Announce Exclusive License and Distribution Agreement for DANYELZA® (naxitamab-gqgk) in Japan - The Manila Times
Vir Biotechnology, Inc. (VIR) Reports Q3 Loss, Lags Revenue Estimates - MSN
Will Y-mAbs Therapeutics, Inc. (YMAB) Report Negative Earnings Next Week? What You Should Know - MSN
Y-mAbs Therapeutics (YMAB) Scheduled to Post Quarterly Earnings on Friday - Defense World
Y-mAbs Therapeutics (YMAB) Scheduled to Post Earnings on Friday - MarketBeat
Positive Outlook For Novartis As Company Capitalizes On Growing Treatment Opportunities, Analyst Highlights - Benzinga
Y-mAbs Therapeutics Investors Get Final OK For $19.7M Deal - Law360
Leptomeningeal Metastases Market to Show Remarkable Growth Trends from 2024 to 2034, DelveInsight Reports | Y-mAbs Therapeutics, Plus Therapeutics, AngioChem, AstraZeneca - The Globe and Mail
Y-mAbs Therapeutics, Inc. (NASDAQ:YMAB) Given Consensus Rating of "Moderate Buy" by Analysts - MarketBeat
Objective long/short (YMAB) Report - Stock Traders Daily
Y-mAbs Announces Third Quarter 2024 Conference Call and Webcast - The Manila Times
Y-Mabs Therapeutics Inc (YMAB-Q) QuotePress Release - The Globe and Mail
13,566 Shares in Y-mAbs Therapeutics, Inc. (NASDAQ:YMAB) Bought by SG Americas Securities LLC - Defense World
Y-mAbs Therapeutics: Slow But Steady Prospect In Rare Cancers (NASDAQ:YMAB) - Seeking Alpha
AQR Capital Management LLC Makes New Investment in TreeHouse Foods, Inc. (NYSE:THS) - Defense World
Cubist Systematic Strategies LLC Has $80,000 Stock Holdings in Y-mAbs Therapeutics, Inc. (NASDAQ:YMAB) - Defense World
Cubist Systematic Strategies LLC Takes Position in Seer, Inc. (NASDAQ:SEER) - Defense World
Summit Materials, Inc. (NYSE:SUM) Shares Bought by SG Americas Securities LLC - Defense World
Pediatric Oncology Drugs Market Size, Share, Growth Insights - openPR
(YMAB) On The My Stocks Page - Stock Traders Daily
Millennium Management LLC Boosts Holdings in Y-mAbs Therapeutics, Inc. (NASDAQ:YMAB) - MarketBeat
Y-mAbs Therapeutics (NASDAQ:YMAB) Stock Price Up 5.7%Still a Buy? - MarketBeat
Y-mAbs Therapeutics Inc (YMAB) Q2 2024 Earnings Call Highlights: Revenue Growth Driven by ... By GuruFocus - Investing.com Canada
Y-mAbs Therapeutics, Inc. (NASDAQ:YMAB) Shares Purchased by Dimensional Fund Advisors LP - MarketBeat
Cubist Systematic Strategies LLC Sells 71,189 Shares of Y-mAbs Therapeutics, Inc. (NASDAQ:YMAB) - MarketBeat
Squarepoint Ops LLC Acquires 74,452 Shares of Y-mAbs Therapeutics, Inc. (NASDAQ:YMAB) - Defense World
Squarepoint Ops LLC Has $1.53 Million Position in Y-mAbs Therapeutics, Inc. (NASDAQ:YMAB) - MarketBeat
Long Term Trading Analysis for (YMAB) - Stock Traders Daily
Y-mAbs Therapeutics (NASDAQ:YMAB) Trading Down 6.1%Here's What Happened - MarketBeat
Y-mAbs Therapeutics (NASDAQ:YMAB) Stock Price Down 6.1% - Defense World
Point72 Asset Management L.P. Sells 1,168,155 Shares of Y-mAbs Therapeutics, Inc. (NASDAQ:YMAB) - MarketBeat
Y-mAbs Therapeutics (NASDAQ:YMAB) Trading Up 6.5% - Defense World
Y-mAbs Therapeutics, Inc. (NASDAQ:YMAB) Given Consensus Rating of “Moderate Buy” by Brokerages - Defense World
Y-mAbs Therapeutics, Inc. (NASDAQ:YMAB) Receives $21.14 Average PT from Analysts - MarketBeat
Y-mAbs to Participate in Upcoming Investor Conferences in October - The Manila Times
Y-mAbs Therapeutics' SWOT analysis: innovative cancer therapy stock faces pivotal year - Investing.com
Radiotheranostics Revolution: What to Expect from the 2024 Global Market As Discussed In New Market Researc... - WhaTech
While shareholders of Y-mAbs Therapeutics (NASDAQ:YMAB) are in the black over 1 year, those who bought a week ago aren't so fortunate - Yahoo Finance
Jamf (NASDAQ:JAMF) Shares Gap Down to $18.70 - MarketBeat
Needham maintains Buy rating on Jamf shares with no price target change - Investing.com India
Jamf (NASDAQ:JAMF) Earns “Market Outperform” Rating from JMP Securities - Defense World
Jamf's (JAMF) Buy Rating Reaffirmed at Needham & Company LLC - MarketBeat
272 Capital LP Acquires 44,486 Shares of Jamf Holding Corp. (NASDAQ:JAMF) - MarketBeat
Y-mAbs Therapeutics (NASDAQ:YMAB) Trading Down 4.7% - MarketBeat
Stock Surge: Y-Mabs Therapeutics Inc (YMAB) Closes at 13.73, Marking a -1.93 Increase/Decrease - The Dwinnex
Examining the Potential Price Growth of Jamf Holding Corp (JAMF) - Knox Daily
How To Trade (YMAB) - Stock Traders Daily
2.02%
0.47%
大文字化:
|
ボリューム (24 時間):